wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q46008297-B1367D2E-D515-457C-B5DE-91E65CDAC9DB
Q46008297-B1367D2E-D515-457C-B5DE-91E65CDAC9DB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46008297-B1367D2E-D515-457C-B5DE-91E65CDAC9DB
The Challenge for Development of Valuable Immuno-oncology Biomarkers.
P2860
Q46008297-B1367D2E-D515-457C-B5DE-91E65CDAC9DB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46008297-B1367D2E-D515-457C-B5DE-91E65CDAC9DB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
608fcc95c9d0a8929543fedcfc0fbbc4bc3f2883
P2860
Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma.